File Download

There are no files associated with this item.

Supplementary

Conference Paper: The use of SECOX (Sorafenib, Oxaliplatin, Capcitabine) as the treatment of advanced hepatocellular carcinoma (HCC): a single center analysis

TitleThe use of SECOX (Sorafenib, Oxaliplatin, Capcitabine) as the treatment of advanced hepatocellular carcinoma (HCC): a single center analysis
Authors
Yau, TCC
Issue Date2012
PublisherDepartment of Medical Oncology, Kinki University Faculty of Medicine.
Citation
10th Annual Meeting of Japanese Society of Medical Oncology (JSMO 2012): Beyond Global Standard of Medical Oncology - Perspectives from Asia, Osaka, Japan, 26-28 July 2012, p. session no. IS1-6 How to Cite?
DescriptionInternational session 1
Persistent Identifierhttp://hdl.handle.net/10722/226197

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.date.accessioned2016-06-15T01:09:29Z-
dc.date.available2016-06-15T01:09:29Z-
dc.date.issued2012-
dc.identifier.citation10th Annual Meeting of Japanese Society of Medical Oncology (JSMO 2012): Beyond Global Standard of Medical Oncology - Perspectives from Asia, Osaka, Japan, 26-28 July 2012, p. session no. IS1-6-
dc.identifier.urihttp://hdl.handle.net/10722/226197-
dc.descriptionInternational session 1-
dc.languageeng-
dc.publisherDepartment of Medical Oncology, Kinki University Faculty of Medicine. -
dc.relation.ispartofAnnual Meeting of Japanese Society of Medical Oncology (JSMO)-
dc.titleThe use of SECOX (Sorafenib, Oxaliplatin, Capcitabine) as the treatment of advanced hepatocellular carcinoma (HCC): a single center analysis-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.hkuros216992-
dc.identifier.spagesession no. IS1-
dc.identifier.epage6-
dc.publisher.placeOsaka, Japan-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats